发明名称 |
Angiotensin II alone or in combination for the treatment of hypotension |
摘要 |
The present invention relates, inter alia, to a method comprising administering to a subject having high output shock and undergoing treatment with a catecholamine at a dose equivalent to at least about 0.2 mcg/kg/min of norepinephrine a dose of angiotensin II which is effective to raise the blood pressure of the subject to a mean arterial pressure (MAP) of about 65 mm Hg or above, and which is effective to reduce the dose of the catecholamine required to maintain a MAP of about 65 mm Hg to the equivalent of about 0.05-0.2 mcg/kg/min norepinephrine or less, or to the equivalent of about 0.05 mcg/kg/min norepinephrine or less. |
申请公布号 |
US9220745(B2) |
申请公布日期 |
2015.12.29 |
申请号 |
US201414575127 |
申请日期 |
2014.12.18 |
申请人 |
The George Washington University, a Congressionally Not-for-Profit Corporation |
发明人 |
Chawla Lakhmir |
分类号 |
A61K38/22;C07K14/575;A61K38/08;A61K31/137 |
主分类号 |
A61K38/22 |
代理机构 |
Venable LLP |
代理人 |
Venable LLP ;Daley Henry J.;Kwok Annette K. |
主权项 |
1. A method of treating a subject having high output shock and undergoing treatment with a catecholamine at a dose equivalent to above about 5 mcg/min of norepinephrine, comprising:
administering angiotensin II to the subject at a rate effective to raise or maintain mean arterial pressure (MAP) of the subject above about 80 mm Hg; reducing the dose of the catecholamine, while maintaining the MAP of the subject above about 80 mm Hg; and reducing the rate at which angiotensin II is administered, while maintaining the MAP of the subject above about 80 mm Hg. |
地址 |
Washington DC US |